Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
5.11
+0.05 (0.99%)
At close: Mar 9, 2026, 4:00 PM EDT
5.09
-0.02 (-0.37%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Niagen Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 410 | 509 | 406 | 108 | 125 | 256 | |
| Market Cap Growth | -0.95% | 25.25% | 277.18% | -14.15% | -50.96% | -14.02% | |
| Enterprise Value | 348 | 448 | 377 | 85 | 117 | 226 | |
| Last Close Price | 5.11 | 6.36 | 5.30 | 1.43 | 1.68 | 3.74 | |
| PE Ratio | 25.55 | 29.26 | 47.50 | - | - | - | |
| Forward PE | 18.93 | 27.81 | 50.28 | - | - | - | |
| PS Ratio | 3.17 | 3.93 | 4.08 | 1.29 | 1.74 | 3.79 | |
| PB Ratio | 5.33 | 6.65 | 8.81 | 3.78 | 4.37 | 8.06 | |
| P/TBV Ratio | 5.79 | 7.18 | 8.88 | 3.85 | 4.48 | 8.29 | |
| P/FCF Ratio | 31.04 | 38.50 | 33.99 | 15.45 | - | - | |
| P/OCF Ratio | 30.37 | 37.67 | 33.54 | 15.13 | - | - | |
| EV/Sales Ratio | 2.69 | 3.46 | 3.78 | 1.01 | 1.62 | 3.35 | |
| EV/EBITDA Ratio | 23.09 | 29.68 | 44.12 | - | - | - | |
| EV/EBIT Ratio | 24.36 | 31.31 | 48.76 | - | - | - | |
| EV/FCF Ratio | 26.36 | 33.87 | 31.54 | 12.17 | - | - | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.06 | 0.12 | 0.15 | 0.15 | |
| Debt / EBITDA Ratio | 0.17 | 0.17 | 0.27 | - | - | - | |
| Debt / FCF Ratio | 0.21 | 0.21 | 0.22 | 0.47 | - | - | |
| Net Debt / Equity Ratio | -0.81 | -0.81 | -0.91 | -0.84 | -0.56 | -0.73 | |
| Net Debt / EBITDA Ratio | -4.10 | -4.10 | -4.90 | 5.23 | 0.91 | 0.90 | |
| Net Debt / FCF Ratio | -4.68 | -4.68 | -3.50 | -3.43 | 1.04 | 0.95 | |
| Asset Turnover | 1.48 | 1.48 | 1.62 | 1.53 | 1.29 | 1.40 | |
| Inventory Turnover | 3.12 | 3.12 | 3.21 | 2.25 | 2.07 | 2.05 | |
| Quick Ratio | 3.73 | 3.73 | 2.91 | 1.57 | 1.61 | 1.89 | |
| Current Ratio | 4.86 | 4.86 | 3.57 | 2.40 | 2.61 | 2.78 | |
| Return on Equity (ROE) | 28.35% | 28.35% | 22.94% | -17.29% | -54.77% | -112.68% | |
| Return on Assets (ROA) | 10.23% | 10.23% | 7.84% | -6.42% | -20.81% | -35.18% | |
| Return on Invested Capital (ROIC) | 112.39% | 144.16% | 169.60% | -65.11% | -176.99% | -542.87% | |
| Return on Capital Employed (ROCE) | 16.50% | 16.50% | 15.40% | -16.30% | -51.50% | -67.30% | |
| Earnings Yield | 4.24% | 3.42% | 2.10% | -4.59% | -13.19% | -10.61% | |
| FCF Yield | 3.22% | 2.60% | 2.94% | 6.47% | -12.31% | -9.61% | |
| Buyback Yield / Dilution | -9.36% | -9.36% | -4.19% | -7.54% | -3.79% | -10.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.